MY BREAST CANCER SUPPORT
MY BREAST CANCER SUPPORT
MY BREAST CANCER SUPPORT
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$574,241
Cash & Equivalents
>99%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$22,002
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$342,534
$574,241
+68%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
-
-
-
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
-
-
-
Total Assets
$342,534
$574,241
+68%
Liabilities
2023
2024
Change
Payables & Accruals
$7,297
$22,002
+202%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$7,297
$22,002
+202%
Net assets
2023
2024
Change
Restricted Net Assets
$7,000
$17,339
+148%
Unrestricted Net Assets
$328,237
$534,900
+63%
Net assets
2023
2024
Change
Net assets
+$335,237
+$552,239
+65%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)